Viewing Study NCT06997159


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-21 @ 1:34 AM
Study NCT ID: NCT06997159
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-30
First Post: 2025-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
Sponsor: Drugs for Neglected Diseases
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-11-16
Start Date Type: ESTIMATED
Primary Completion Date: 2027-07-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07-10
Completion Date Type: ESTIMATED
First Submit Date: 2025-05-13
First Submit QC Date: None
Study First Post Date: 2025-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-21
Last Update Post Date: 2025-05-30
Last Update Post Date Type: ACTUAL